Pituitary adenylate cyclase-actviating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells

Atsushi Suzuki, Jun Kotoyori, Yutaka Oiso, Osamu Kaozawa

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) isolated from ovine hypothalamic tissue is a novel neuropeptide which stimulates adenylate cyclase in rat anterior pituitary cell cultures. In osteoblasts, the detail in intracellular signalling systems of PACAP has not yet been clarified. In this study, we investigated the effects of PACAP on cAMP accumulation, phosphoinositide hydrolysis and Ca2+ influx in osteoblast-like MC3T3-E1 cells, compared with those of vasoactive intestinal polypeptide (VIP), which shows a considerable homology with PACAP in the N-terminal sequence. PACOA stimulated cAMP accumulation in a dose-dependent manner in the range between 0.1 nM and 0.1 μM in these cells. VIP also stimulated cAMP accumulation dose-dependently between 1 nM and 0.1 μM. The effect of PACAP on cAMP accumulation (ec50 = 3 nM) was more potent than that of VIP (ec50 = 30 nM). The cAMP accumulation stimulated by a combinatiion of PACAP (3 nM) and VIP (30 nM) was additive. [Lys1, Pro2,5, Arg3,4, Tyr6]-VIP, an antagonist for the VIP receptor which markedly inhibited the VIP-induced cAMP accumulation, had little effect on the PACAP-induced cAMP accumulation. Either PACAP or VIP had little effect on the formation of inositol phosphates and Ca2+ influx in these cells. These results strongly suggest that PACAP stimulates cAMP production via an independent binding site from VIP osteoblast-like MC3AT3-E1 cells and that PACAp has no effect on the activation of protein kinase C nor the intracellular CA2+ mobilization in these cells.

Original languageEnglish
Pages (from-to)11-16
Number of pages6
JournalCellular Signalling
Volume6
Issue number1
DOIs
Publication statusPublished - 01-1994

Fingerprint

Pituitary Adenylate Cyclase-Activating Polypeptide
Vasoactive Intestinal Peptide
Osteoblasts
Adenylyl Cyclases
Peptides
Inositol Phosphates
Phosphatidylinositols
Neuropeptides
Protein Kinase C
Sheep
Hydrolysis
Cell Culture Techniques
Binding Sites

All Science Journal Classification (ASJC) codes

  • Cell Biology

Cite this

@article{bc616750cb1940b88169c379d6910156,
title = "Pituitary adenylate cyclase-actviating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells",
abstract = "Pituitary adenylate cyclase-activating polypeptide (PACAP) isolated from ovine hypothalamic tissue is a novel neuropeptide which stimulates adenylate cyclase in rat anterior pituitary cell cultures. In osteoblasts, the detail in intracellular signalling systems of PACAP has not yet been clarified. In this study, we investigated the effects of PACAP on cAMP accumulation, phosphoinositide hydrolysis and Ca2+ influx in osteoblast-like MC3T3-E1 cells, compared with those of vasoactive intestinal polypeptide (VIP), which shows a considerable homology with PACAP in the N-terminal sequence. PACOA stimulated cAMP accumulation in a dose-dependent manner in the range between 0.1 nM and 0.1 μM in these cells. VIP also stimulated cAMP accumulation dose-dependently between 1 nM and 0.1 μM. The effect of PACAP on cAMP accumulation (ec50 = 3 nM) was more potent than that of VIP (ec50 = 30 nM). The cAMP accumulation stimulated by a combinatiion of PACAP (3 nM) and VIP (30 nM) was additive. [Lys1, Pro2,5, Arg3,4, Tyr6]-VIP, an antagonist for the VIP receptor which markedly inhibited the VIP-induced cAMP accumulation, had little effect on the PACAP-induced cAMP accumulation. Either PACAP or VIP had little effect on the formation of inositol phosphates and Ca2+ influx in these cells. These results strongly suggest that PACAP stimulates cAMP production via an independent binding site from VIP osteoblast-like MC3AT3-E1 cells and that PACAp has no effect on the activation of protein kinase C nor the intracellular CA2+ mobilization in these cells.",
author = "Atsushi Suzuki and Jun Kotoyori and Yutaka Oiso and Osamu Kaozawa",
year = "1994",
month = "1",
doi = "10.1016/0898-6568(94)90056-6",
language = "English",
volume = "6",
pages = "11--16",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "1",

}

Pituitary adenylate cyclase-actviating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells. / Suzuki, Atsushi; Kotoyori, Jun; Oiso, Yutaka; Kaozawa, Osamu.

In: Cellular Signalling, Vol. 6, No. 1, 01.1994, p. 11-16.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pituitary adenylate cyclase-actviating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells

AU - Suzuki, Atsushi

AU - Kotoyori, Jun

AU - Oiso, Yutaka

AU - Kaozawa, Osamu

PY - 1994/1

Y1 - 1994/1

N2 - Pituitary adenylate cyclase-activating polypeptide (PACAP) isolated from ovine hypothalamic tissue is a novel neuropeptide which stimulates adenylate cyclase in rat anterior pituitary cell cultures. In osteoblasts, the detail in intracellular signalling systems of PACAP has not yet been clarified. In this study, we investigated the effects of PACAP on cAMP accumulation, phosphoinositide hydrolysis and Ca2+ influx in osteoblast-like MC3T3-E1 cells, compared with those of vasoactive intestinal polypeptide (VIP), which shows a considerable homology with PACAP in the N-terminal sequence. PACOA stimulated cAMP accumulation in a dose-dependent manner in the range between 0.1 nM and 0.1 μM in these cells. VIP also stimulated cAMP accumulation dose-dependently between 1 nM and 0.1 μM. The effect of PACAP on cAMP accumulation (ec50 = 3 nM) was more potent than that of VIP (ec50 = 30 nM). The cAMP accumulation stimulated by a combinatiion of PACAP (3 nM) and VIP (30 nM) was additive. [Lys1, Pro2,5, Arg3,4, Tyr6]-VIP, an antagonist for the VIP receptor which markedly inhibited the VIP-induced cAMP accumulation, had little effect on the PACAP-induced cAMP accumulation. Either PACAP or VIP had little effect on the formation of inositol phosphates and Ca2+ influx in these cells. These results strongly suggest that PACAP stimulates cAMP production via an independent binding site from VIP osteoblast-like MC3AT3-E1 cells and that PACAp has no effect on the activation of protein kinase C nor the intracellular CA2+ mobilization in these cells.

AB - Pituitary adenylate cyclase-activating polypeptide (PACAP) isolated from ovine hypothalamic tissue is a novel neuropeptide which stimulates adenylate cyclase in rat anterior pituitary cell cultures. In osteoblasts, the detail in intracellular signalling systems of PACAP has not yet been clarified. In this study, we investigated the effects of PACAP on cAMP accumulation, phosphoinositide hydrolysis and Ca2+ influx in osteoblast-like MC3T3-E1 cells, compared with those of vasoactive intestinal polypeptide (VIP), which shows a considerable homology with PACAP in the N-terminal sequence. PACOA stimulated cAMP accumulation in a dose-dependent manner in the range between 0.1 nM and 0.1 μM in these cells. VIP also stimulated cAMP accumulation dose-dependently between 1 nM and 0.1 μM. The effect of PACAP on cAMP accumulation (ec50 = 3 nM) was more potent than that of VIP (ec50 = 30 nM). The cAMP accumulation stimulated by a combinatiion of PACAP (3 nM) and VIP (30 nM) was additive. [Lys1, Pro2,5, Arg3,4, Tyr6]-VIP, an antagonist for the VIP receptor which markedly inhibited the VIP-induced cAMP accumulation, had little effect on the PACAP-induced cAMP accumulation. Either PACAP or VIP had little effect on the formation of inositol phosphates and Ca2+ influx in these cells. These results strongly suggest that PACAP stimulates cAMP production via an independent binding site from VIP osteoblast-like MC3AT3-E1 cells and that PACAp has no effect on the activation of protein kinase C nor the intracellular CA2+ mobilization in these cells.

UR - http://www.scopus.com/inward/record.url?scp=0028264854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028264854&partnerID=8YFLogxK

U2 - 10.1016/0898-6568(94)90056-6

DO - 10.1016/0898-6568(94)90056-6

M3 - Article

C2 - 7912096

AN - SCOPUS:0028264854

VL - 6

SP - 11

EP - 16

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 1

ER -